Arihant Capital Markets Ltd Upgraded to Sell on Valuation Improvement

Valuation Upgrade Spurs Rating Improvement

The most notable catalyst behind the rating upgrade is the marked enhancement in Arihant Capital’s valuation profile. The company’s price-to-earnings (PE) ratio stands at 19.70, which is considerably lower than many of its capital markets peers such as Mufin Green (PE 90.11) and Ashika Credit (PE 157.87). This valuation discount is further supported by an enterprise value to EBITDA (EV/EBITDA) multiple of 7.39 and an EV to EBIT ratio of 7.75, both indicating a relatively inexpensive stock price compared to earnings before interest, taxes, depreciation, and amortisation.

Additionally, the price-to-book (P/B) value of 1.84 and a dividend yield of 0.68% add to the attractiveness of the stock’s valuation. The PEG ratio remains at zero, signalling no expected earnings growth priced in, which may present upside potential if the company can reverse its recent profit declines. The return on capital employed (ROCE) is robust at 36.64%, underscoring efficient capital utilisation despite current earnings pressures.

Financial Trend Remains Challenging

Despite the valuation appeal, Arihant Capital’s financial trend continues to show weakness. The company has reported negative results for five consecutive quarters, with the latest quarter’s profit after tax (PAT) falling sharply by 52.1% to ₹5.18 crores compared to the previous four-quarter average. Net sales for the nine months ended have declined by 21.98% to ₹156.80 crores, while profit before depreciation, interest, and taxes (PBDIT) hit a low of ₹13.93 crores in the most recent quarter.

This persistent downturn in earnings has weighed on investor sentiment, reflected in the stock’s underperformance relative to the broader market. Over the past year, Arihant Capital’s share price has declined by 4.11%, whereas the BSE500 index has delivered a positive return of 6.18%. The year-to-date return is even more stark, with the stock down 22.73% compared to the Sensex’s 10.74% loss, highlighting the company’s struggles to keep pace with market benchmarks.

Quality Assessment and Long-Term Fundamentals

From a quality perspective, Arihant Capital maintains a strong long-term fundamental base despite recent setbacks. The company’s average return on equity (ROE) over time is a healthy 17.29%, although the latest ROE has moderated to 10.43%. This suggests that while profitability has softened, the firm’s ability to generate returns on shareholder capital remains above average within the capital markets sector.

However, the company’s micro-cap status and limited institutional ownership—domestic mutual funds hold effectively zero stake—indicate a lack of broad market confidence. This absence of significant institutional backing may reflect concerns about the company’s recent financial performance and growth prospects.

Technical Indicators and Market Performance

Technically, Arihant Capital’s share price has shown volatility within a 52-week range of ₹56.31 to ₹120.35. The current price of ₹69.47 is closer to the lower end of this range, suggesting limited upside momentum in the near term. The stock’s day change of 0.29% on 18 Mar 2026 indicates modest trading activity without strong directional conviction.

Comparing returns over longer horizons, the stock has delivered impressive gains of 76.77% over three years and a remarkable 1,254.19% over ten years, far outpacing the Sensex’s 31.18% and 208.26% returns respectively. This long-term outperformance highlights the company’s potential for value creation, albeit tempered by recent operational challenges.

Summary of Rating Change and Outlook

The upgrade from Strong Sell to Sell reflects a nuanced view of Arihant Capital Markets Ltd’s current standing. The very attractive valuation grade, supported by reasonable PE and EV multiples and strong capital efficiency, has improved the stock’s investment appeal. Yet, the persistent negative financial trends, lack of institutional interest, and subdued technical momentum temper enthusiasm.

Investors should weigh the company’s attractive price against the risks posed by ongoing earnings declines and market underperformance. The micro-cap nature of the stock adds an additional layer of volatility and liquidity considerations. For those with a longer-term horizon, the company’s historical returns and solid ROCE may offer a foundation for recovery, but caution remains warranted in the near term.

Overall, the revised Sell rating signals a modestly less pessimistic stance, recognising valuation improvements while acknowledging the need for financial turnaround and stronger market support before a more positive outlook can be justified.

Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Start Today